In a high-profile studio scramble, Austin Butler is attached to portray Lance Armstrong in a new biopic to be directed by Edward Berger, Deadline reports. The screenplay is being written by Zach Baylin, with producers Scott Stuber, Nick Nesbit and Berger leading the package and Josh Glick and Zac Frognowski serving as executive producers alongside Baylin. Sources say the package has triggered competitive offers from multiple major studios; the package predates Stuber’s relaunch of United Artists and therefore bypasses Amazon MGM Studios’ first-look position. Armstrong has reportedly signed off on life-rights for the first time, with producers saying the film will cover both his celebrated comebacks and the doping revelations that later ended his career.
Key Takeaways
- Austin Butler is attached to play Lance Armstrong, with Edward Berger set to direct and Zach Baylin writing the screenplay.
- Scott Stuber and Nick Nesbit are producing; Josh Glick and Zac Frognowski are executive producers alongside Baylin.
- The project has prompted a multi-studio bidding situation, according to industry sources, with offers from several major studios.
- Stuber’s pursuit of Armstrong’s life rights predates his relaunch of United Artists, which is why Amazon MGM Studios does not hold first dibs.
- This will be the first film based on Armstrong’s life with his formal sign-off, and producers say nothing will be off limits.
- The film aims for a tonal blend likened to F1: The Movie and Scorsese titles such as Raging Bull and The Wolf of Wall Street.
- Austin Butler is an Oscar nominee for Elvis; Berger and Butler have previously been paired on other high-profile packages that attracted industry attention.
Background
Lance Armstrong’s life arc—surviving metastatic testicular cancer, returning to elite professional cycling and winning seven consecutive Tour de France titles from 1999 to 2005—has long captivated filmmakers and the public. The later collapse of that public narrative, after years of denial and an eventual admission of blood-doping, transformed his story from triumphant comeback to a cautionary tale about performance-enhancing drugs and sporting governance. Hollywood has previously dramatized aspects of Armstrong’s story: the 2015 film The Program depicted the doping scandal with Ben Foster portraying Armstrong without Armstrong’s participation or approval.
Scott Stuber has established a track record producing films centered on prominent cultural figures and tentpole material; his slate includes recent large-scale projects and features produced for global streamers. Zach Baylin’s screenplay credits include high-profile biographical work, and Edward Berger is recognized for character-driven direction. That combination—an actor with awards recognition, a writer experienced in biopics, and a director with an auteur profile—helps explain the intense studio interest reported around the package.
Main Event
Sources tell Deadline that Butler is now attached to star and Berger will direct from a Baylin spec script. Stuber and Nesbit are listed as producers; Berger and Baylin are also producing alongside the executive producers. Industry insiders characterize offers from multiple major studios, though the precise bidders have not been publicly disclosed. The package’s movement into the open market stems from a rights pursuit that predated Stuber’s United Artists relaunch and his subsequent deal with Amazon.
According to reporting, Stuber negotiated for Armstrong’s life rights over an extended period and set a condition with Armstrong that the project would tell the full story—warts and all—or Armstrong would not participate. After sustained conversations, Armstrong reportedly agreed to sign off, marking the first time he has authorized a film based on his life. Baylin has reportedly interviewed Armstrong and people close to him; producers say there are no narrative exclusions.
Studio executives and representatives are said to be evaluating the tone and scope: producers aim to balance Armstrong’s athletic achievements and his public fall from grace, framing the film as both a sports drama and a character study. Butler’s casting follows his Oscar-nominated performance as Elvis Presley; Berger’s involvement lends the project arthouse credibility even as producers aim for a film with wide domestic and international appeal. The package’s momentum has drawn attention partly because of the marketability of Butler and the controversy inherent in Armstrong’s story.
Analysis & Implications
The Armstrong life story presents both opportunity and risk for studios. On one hand, it contains the cinematic beats that often drive awards-season biopics: personal adversity, public triumph, celebrity and moral failure. On the other, it carries reputational complexity due to the doping scandal and the many stakeholders involved, including governing bodies, former teammates and sponsors. A film with Armstrong’s cooperation could open access to primary sources and a more personal point of view, but it also raises questions about editorial independence and how controversial episodes will be framed.
For Austin Butler, the role is a potential next step following his critically recognized turn as Elvis; playing Armstrong offers a demanding physical and psychological transformation that could further solidify Butler’s status as a lead actor in prestige cinema. For Edward Berger and Zach Baylin, the film would extend their portfolios into a mainstream cinematic biography with substantial commercial prospects. For Scott Stuber and financiers, the package’s bidding competition highlights the commercial value of star-driven true stories—especially those with built-in public recognition and international resonance.
International distribution and streaming rights will be critical to the project’s economics. Sports dramas that center on global competitions—like the Tour de France—tend to attract cross-border audiences, but the market’s tolerance for moral complexity varies by territory. Studios weighing bids will need to account for potential legal clearances (image rights, archival footage) and the marketing challenge of presenting a story about a celebrated athlete who was later discredited. How the film positions Armstrong—sympathetic subject, opportunistic figure, or complex mixture—will shape both critical reception and box-office performance.
Comparison & Data
| Item | Detail |
|---|---|
| Tour de France victories | Seven consecutive wins (1999–2005; later vacated) |
| Cancer survival | Diagnosed with metastatic testicular cancer in 1996; returned to competition |
| Doping admission | Admitted to blood doping in 2013 after years of denial |
| Previous film depiction | The Program (2015), Ben Foster as Armstrong (no Armstrong involvement) |
The table places the core factual milestones alongside prior screen treatment. Context matters: Armstrong’s seven Tour de France wins were foundational to his celebrity, though those results were later annulled by cycling authorities; his cancer survival remains an undisputed element of his public narrative. The new project’s reported access to Armstrong’s life rights could afford filmmakers primary testimony, but it will still require independent corroboration for contested episodes.
Reactions & Quotes
Industry response has been swift, with agents and studios said to be circulating offers and assessing production plans. Below are brief statements attributed to reporting sources and industry participants, framed with context rather than long direct testimony.
“This package lit up the market—multiple major studios are putting forward offers,”
Industry source via Deadline (trade reporting)
That characterization summarizes how the project moved quickly into a competitive phase; sources described the activity as a traditional studio bidding process rather than an exclusive studio assignment. Representatives for the parties involved have not released formal public statements confirming bidder identities.
“We needed to tell everything or he didn’t want to do the film,”
Paraphrased from Deadline reporting on Scott Stuber’s discussions with Armstrong
This paraphrase reflects the reported condition Stuber set when negotiating Armstrong’s participation: full transparency about the athlete’s life. Producers say those terms were central to securing Armstrong’s sign-off and shape the creative brief for the script and production.
Unconfirmed
- Specific studio bidders and the size of individual offers have not been publicly confirmed beyond industry reporting.
- The exact contractual terms of Armstrong’s life-rights agreement—including approval rights or narrative carve-outs—have not been released.
- Details about production timeline, shooting locations, and a projected release window remain unannounced.
Bottom Line
The Butler–Berger–Baylin–Stuber package places one of sport’s most dramatic and contentious stories back in Hollywood’s spotlight, this time with the subject’s reported cooperation. That combination—an A-list actor, an acclaimed director, a proven biopic writer and a persistent producer—has made the project attractive to major studios despite the reputational risks associated with Armstrong’s doping scandal.
How the film is framed will determine both its cultural impact and commercial prospects: a candid, critically rigorous treatment could earn awards attention and reframe public understanding, while a more sympathetic or revisionist approach could prompt scrutiny from journalists, former competitors and cycling authorities. For now, industry watchers will be watching the bidding process and any production announcements for signs of the film’s scale, tone and distribution plan.
Sources
- Deadline (entertainment trade reporting)